Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Protein Pept Sci ; 25(6): 443-453, 2024.
Article in English | MEDLINE | ID: mdl-38284715

ABSTRACT

Lectins are proteins widely distributed among plants, animals and microorganisms that have the ability to recognize and interact with specific carbohydrates. They have varied biological activities, such as the inhibition of the progression of infections caused by fungi, bacteria, viruses and protozoa, which is related to the interaction of these proteins with the carbohydrates present in the cell walls of these microorganisms. Leishmaniasis are a group of endemic infectious diseases caused by protozoa of the genus Leishmania. In vitro and in vivo tests with promastigotes and amastigotes of Leishmania demonstrated that lectins have the ability to interact with glycoconjugates present on the cell surface of the parasite, it prevents their development through various mechanisms of action, such as the production of ROS and alteration of membrane integrity, and can also interact with defense cells present in the human body, thus showing that these molecules can be considered alternative pharmacological targets for the treatment of leishmaniasis. The objective of the present work is to carry out a bibliographic review on lectins with leishmanicidal activity, emphasizing the advances and perspectives of research in this theme. Through the analysis of the selected studies, we were able to conclude that lectins have great potential for inhibiting the development of leishmaniasis. However, there are still few studies on this subject.


Subject(s)
Lectins , Leishmania , Leishmaniasis , Leishmania/drug effects , Humans , Lectins/pharmacology , Lectins/chemistry , Lectins/metabolism , Leishmaniasis/drug therapy , Leishmaniasis/parasitology , Animals , Antiprotozoal Agents/pharmacology , Antiprotozoal Agents/chemistry , Reactive Oxygen Species/metabolism
2.
Curr Protein Pept Sci ; 23(12): 851-861, 2022.
Article in English | MEDLINE | ID: mdl-36239726

ABSTRACT

The indiscriminate use of antibiotics is associated with the appearance of bacterial resistance. In light of this, plant-based products treating infections are considered potential alternatives. Lectins are a group of proteins widely distributed in nature, capable of reversibly binding carbohydrates. Lectins can bind to the surface of pathogens and cause damage to their structure, thus preventing host infection. The antimicrobial activity of plant lectins results from their interaction with carbohydrates present in the bacterial cell wall and fungal membrane. The data about lectins as modulating agents of antibiotic activity, potentiates the effect of antibiotics without triggering microbial resistance. In addition, lectins play an essential role in the defense against fungi, reducing their infectivity and pathogenicity. Little is known about the antiviral activity of plant lectins. However, their effectiveness against retroviruses and parainfluenza is reported in the literature. Some authors still consider mannose/ glucose/N-Acetylglucosamine binding lectins as potent antiviral agents against coronavirus, suggesting that these lectins may have inhibitory activity against SARS-CoV-2. Thus, it was found that plant lectins are an alternative for producing new antimicrobial drugs, but further studies still need to decipher some mechanisms of action.


Subject(s)
Anti-Infective Agents , COVID-19 , Humans , Plant Lectins/pharmacology , SARS-CoV-2 , Lectins/pharmacology , Anti-Infective Agents/pharmacology , Antiviral Agents/pharmacology , Carbohydrates , Anti-Bacterial Agents
SELECTION OF CITATIONS
SEARCH DETAIL
...